CHI3L1 and Alzheimer disease: To further investigate whether age at onset (AAO) modulates peripheral CHI3L1 expression, we stratified the MCI and AD cohorts into early-onset (EO; AAO < 65 years), and late-onset (LO; AAO ≥ 65 years) subgroups.